This year's Nobel Prize in Physiology or Medicine has been awarded to three scientists for their work on regulatory T-cells ...

Kronos was bought out earlier this year for a knockdown price of around $35 million by serial biotech acquisition specialist ...

Last year, Idorsia Pharma claimed FDA approval for Tryvio (aprocitentan) as the first endothelin receptor antagonist for ...

Radiopharmaceuticals have rapidly evolved from a specialised therapeutic niche into a cornerstone of modern oncology. By ...

Roche's entry into the category with afimkibart (RG6631) stemmed from its purchase of Telavant for $7.1 billion, and since then it has advanced the drug into a phase 3 programme, also in inflammatory ...

While advances in drug development have accelerated dramatically in recent years, pharmaceutical manufacturing processes have ...

Trump called for the MMR vaccine – a pillar of childhood immunisation that protects against measles, mumps, and rubella (whooping cough) – to be broken up into three shots given separately in a Truth ...

Privosegtor is Oculis ' second ophthalmic drug to start a pivotal trials programme after OCS-01, a topical anti-TNF drug in ...

Scotland was held up as proof that new models of adoption, AI-enabled diagnostics, and genomics can transform care at pace.

The algorithm will be added to Roche's navify library of clinical decision-making algorithms and other digital health ...

Edinburgh, Scotland-based start-up Trogenix has raised £70 million ($95 million) for a pipeline of therapies for ...

The results of the TROPION-Breast02 trial of the TROP2-targeting antibody-drug conjugate (ADC) were originally due to be ...